Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
7,590.00
-270.00 (-3.44%)
At close: Mar 28, 2025, 3:30 PM KST
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 55.80B KRW in the quarter ending September 30, 2024, with 13.56% growth. This brings the company's revenue in the last twelve months to 215.44B, up 2.88% year-over-year. In the year 2023, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 200.23B, down -4.33%.
Revenue (ttm)
215.44B
Revenue Growth
+2.88%
P/S Ratio
1.75
Revenue / Employee
271.28M
Employees
815
Market Cap
397.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
Dec 31, 2019 | 189.72B | 2.33B | 1.24% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |